Treatment of Diarrhea-Associated Fecal Incontinence With Eluxadoline
Status: Withdrawn prior to enrolment
Phase of Trial: Phase II
Latest Information Update: 26 Jul 2019
Price : $35 *
At a glance
- Drugs Eluxadoline (Primary)
- Indications Diarrhoea; Faecal incontinence
- Focus Therapeutic Use
- Acronyms ELXDFI
- 23 Jul 2019 Status changed from not yet recruiting to withdrawn prior to enrolment.
- 26 Feb 2019 Planned initiation date changed from 1 Jan 2019 to 1 Apr 2019.
- 03 Dec 2018 Planned initiation date changed from 30 Aug 2018 to 1 Jan 2019.